Use of traditional Chinese medicine in the treatment of immune-related adverse events of cancer immu

• 作 者: Li Hou Liya Ju Jing Wang Tian
• 机 构: Department of Hematology and Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine,
• 出 处: 中医科学杂志（英文）
• 发表日期: 2018年4期
• 关键词: Immune-related adverse events Traditional Chinese medicine Cancer immunotherapy

Immune checkpoint inhibitors (ICPI) have shown considerable promise in the treatment of tumors.However,immune-related adverse events (irAEs) caused by ICPI have been reported in nearly every organ system.Whilst this represents a new challenge in the field of cancer treatment,traditional Chinese medicine (TCM) provides benefits in the treatment of irAEs.This article reviews the studies of the treatment of immune-related gastrointestinal diseases and dermatosis with TCM and introduces the collaborative efforts between China and France in the implementation of TCM for the treatment of irAEs.